Clinical Trials · NCT00866554
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- CHU de Quebec-Universite Laval
- Enrollment
- 60
- Start date
- Mar 2009
- Locations
- 1 site, Canada
- Primary endpoint
- Total prostate volume